Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Jakob

Showing results (621-630 of 630) with videos related to

Pageof 63
Sort By:
You have reached the last page of results.This site can display upto 630 results.
Acta Anaesthesiologica Scandinavica|February 14, 2021
Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysisAnders Granholm, Marie Warrer Munch, Sheila Nainan Myatra, et al.
Intensive Care Medicine|November 10, 2021
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trialAnders Granholm, Marie Warrer Munch, Sheila Nainan Myatra, et al.
Intensive Care Medicine|April 1, 2022
Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemiaAnders Granholm, Maj-Brit Nørregaard Kjær, Marie Warrer Munch, et al.
Stroke|December 4, 2020
Incidence and Outcome of Aneurysmal Subarachnoid Hemorrhage: The Swiss Study on Subarachnoid Hemorrhage (Swiss SOS)Bawarjan Schatlo, Christian Fung, Martin N Stienen, et al.
Intensive Care Medicine|June 18, 2023
Long-term effects of restriction of intravenous fluid in adult ICU patients with septic shockMaj-Brit Nørregaard Kjær, Tine Sylvest Meyhoff, Praleene Sivapalan, et al.
Critical Care (London, England)|July 5, 2022
Dynamics of disease characteristics and clinical management of critically ill COVID-19 patients over the time course of the pandemic: an analysis of the prospective, international, multicentre RISC-19-ICU registryPedro David Wendel-Garcia, André Moser, Marie-Madlen Jeitziner, et al.
The New England Journal of Medicine|June 16, 2022
Restriction of Intravenous Fluid in ICU Patients with Septic ShockTine S Meyhoff, Peter B Hjortrup, Jørn Wetterslev, et al.
The New England Journal of Medicine|October 26, 2018
Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICUMette Krag, Søren Marker, Anders Perner, et al.
Acta Anaesthesiologica Scandinavica|June 17, 2021
Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: The COVID STEROID randomised, placebo-controlled trialMarie Warrer Munch, Tine Sylvest Meyhoff, Marie Helleberg, et al.
JAMA|October 21, 2021
Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial, Marie W Munch, Sheila N Myatra, et al.
Pageof 63

Showing results (621-630 of 630) with videos related to

Sort By:
Pageof 63
You have reached the last page of results.This site can display upto 630 results.
Acta Anaesthesiologica Scandinavica|February 14, 2021
Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysisAnders Granholm, Marie Warrer Munch, Sheila Nainan Myatra, et al.
Intensive Care Medicine|November 10, 2021
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trialAnders Granholm, Marie Warrer Munch, Sheila Nainan Myatra, et al.
Intensive Care Medicine|April 1, 2022
Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemiaAnders Granholm, Maj-Brit Nørregaard Kjær, Marie Warrer Munch, et al.
Stroke|December 4, 2020
Incidence and Outcome of Aneurysmal Subarachnoid Hemorrhage: The Swiss Study on Subarachnoid Hemorrhage (Swiss SOS)Bawarjan Schatlo, Christian Fung, Martin N Stienen, et al.
Intensive Care Medicine|June 18, 2023
Long-term effects of restriction of intravenous fluid in adult ICU patients with septic shockMaj-Brit Nørregaard Kjær, Tine Sylvest Meyhoff, Praleene Sivapalan, et al.
Critical Care (London, England)|July 5, 2022
Dynamics of disease characteristics and clinical management of critically ill COVID-19 patients over the time course of the pandemic: an analysis of the prospective, international, multicentre RISC-19-ICU registryPedro David Wendel-Garcia, André Moser, Marie-Madlen Jeitziner, et al.
The New England Journal of Medicine|June 16, 2022
Restriction of Intravenous Fluid in ICU Patients with Septic ShockTine S Meyhoff, Peter B Hjortrup, Jørn Wetterslev, et al.
The New England Journal of Medicine|October 26, 2018
Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICUMette Krag, Søren Marker, Anders Perner, et al.
Acta Anaesthesiologica Scandinavica|June 17, 2021
Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: The COVID STEROID randomised, placebo-controlled trialMarie Warrer Munch, Tine Sylvest Meyhoff, Marie Helleberg, et al.
JAMA|October 21, 2021
Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial, Marie W Munch, Sheila N Myatra, et al.
Pageof 63